SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-23-097877
Filing Date
2023-12-22
Accepted
2023-12-22 09:11:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ea190562-f1a1_scinai.htm F-1/A 363164
2 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ea190562ex23-1_scinai.htm EX-23.1 3203
3 GRAPHIC image_001.jpg GRAPHIC 16430
  Complete submission text file 0001213900-23-097877.txt   390355
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-275217 | Film No.: 231507430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)